Shayona Eng. (544686)

Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 29.66% is genuinely high, suggesting the existing capital base earns well if the number is sustainable.
• Sales and profit growth are flat at 0.00%, not negative; the business is not visibly shrinking.
• Market cap of ₹54 Cr gives a very small base; a modest recovery in orders could move the needle.
• As a listed NSE/BSE microcap, the stock provides an exit, though liquidity may be thin.

Concerns

• Latest quarter shows ₹0 Cr sales and ₹0 Cr net profit, making current operations impossible to verify.
• Piotroski F-Score of 3/9 signals weak financial health and possible deterioration.
• P/E of 22.05 with zero growth and no dividend is an expensive combination for a microcap.
• Missing book value, debt/equity, promoter holding, and 52-week range create an information blackout; FairStock itself says INSUFFICIENT_DATA.

AI Analysis

At first glance, this is the kind of small-cap that makes me want to stop before reaching for my wallet. A market cap of just ₹54 crore is tiny, and a P/E of 22.05 is not cheap for a company showing zero sales growth and zero profit growth. Graham would ask: what am I actually paying for? The latest quarter reports sales of ₹0 crore and net profit of ₹0 crore—either the business is temporarily stalled or the reporting is incomplete. Either way, I cannot put real money on a blank page. The one number that catches my eye is ROCE of 29.66%. That is an unusually high return on capital, if it is genuine and recurring. But high returns with zero growth and a Piotroski score of 3/9 tell me something may be deteriorating. A 3/9 score is a clear warning on profitability, balance-sheet strength, and efficiency. There is no dividend to pay me to wait, and with no book value, debt-equity ratio, promoter holding, or 52-week range disclosed, I do not have enough facts to value the business. In castings and forgings, cycles are real; today's high ROCE can disappear when order books thin or raw material costs rise. The market is pricing this at twenty-two times earnings, but earnings appear flat at best. FairStock itself says INSUFFICIENT_DATA. In Graham's words, price is what you pay, value is what you get—and here I cannot calculate value. I would rather miss an uncertain compounder than buy a microcap with incomplete numbers and stagnant operations.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer